FGF-23 as a predictor of 6-month outcome and response to therapy in acute heart failure

Back

ACVC Premium Access

FGF-23 as a predictor of 6-month outcome and response to therapy in acute heart failure

Session: AHF and CS - methods, predictors and interventions

Topic: Biomarkers

Speaker: Professor M. Gierlotka (Opole, PL)

Event: ESC Acute CardioVascular Care 2022

Congress Presentation

Add to my library

About the speaker

Professor Marek Gierlotka

University of Opole, Opole (Poland)

5 presentations

0 follower

6 more presentations in this session

Arrhythmia-induced cardiomyopathy: unveiled after electrical cardioversion

Speaker: Doctor R. Menezes Fernandes (Faro, PT)

A novel method of approximating pressure-volume loops in the cardiac intensive care unit

Speaker: Doctor A. Papolos (Washington, US)

Protective role of protein Klotho biomarker in acute heart failure

Speaker: Doctor J. Plonka (Opole, PL)

Acute hemodynamic effect of ketone bodies in patients with decompensated heart failure

Speaker: Doctor M. Sramko (Prague, CZ)

Predictors of non-invasive ventilation failure in adult patients with cardiac dysfunction presenting with community acquired pneumonia; an Egyptian multicenter prospective study

Speaker: Assistant Professor M. Laimoud (Riyadh, SA)

Access the full session

AHF and CS - methods, predictors and interventions

Speakers: Professor M. Gierlotka, Doctor R. Menezes Fernandes, Doctor A. Papolos, Doctor J. Plonka, Doctor M. Sramko...

Access

About the event

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources